Starting at 1.0 mg significantly increases the risk of nausea, vomiting, and other gastrointestinal side effects
In the SURMOUNT clinical trial, tirzepatide produced greater average weight loss (up to 22.5% of body weight) compared to semaglutide (up to 17.5% at the highest tested dose)
This recipe works particularly well for people who are following a food list for semaglutide and want to increase their nutrient density without increasing volume
This is called early worsening and usually passes, but it requires monitoring
Each medication may also have contraindications with underlying health conditions you may have or other medications you may be taking, Dr
The FDA has advised patients to be cautious about compounded GLP-1 drugs, emphasizing that it does not evaluate these medications for safety, quality, or efficacy before theyre sold